GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Neuro-Oncology, Oxford University Press (OUP), ( 2023-08-08)
    Abstract: Glioblastoma (GBM) is refractory to current treatment modalities while side effects of treatments result in neurotoxicity and cognitive impairment. Here we test the hypothesis that inhibiting CDK7 or CDK9 would effectively combat GBM with reduced neurotoxicity. Methods We examined the effect of a CDK7 inhibitor, THZ1, and multiple CDK9 inhibitors (SNS032, AZD4573, NVP2, and JSH150) on GBM cell lines, patient-derived temozolomide (TMZ)-resistant and responsive primary tumor cells and glioma stem cells (GSCs). Biochemical changes were assessed by western blotting, immunofluorescence, multispectral imaging, and RT-PCR. In vivo, efficacy was assessed in orthotopic and subcutaneous xenograft models. Results CDK7 and CDK9 inhibitors suppressed the viability of TMZ-responsive and resistant GBM cells and GSCs at low nanomolar concentrations, with limited cytotoxic effects in vivo. The inhibitors abrogated RNA Pol II and p70S6K phosphorylation and nascent protein synthesis. Furthermore, the self-renewal of GSCs was significantly reduced with a corresponding reduction in Sox2 and Sox9 levels. Analysis of TCGA data showed increased expression of CDK7, CDK9, SOX2, SOX9, and RPS6KB1 in GBM; supporting this, multispectral imaging of a TMA revealed increased levels of CDK9, Sox2, Sox9, phospho-S6, and phospho-p70S6K in GBM compared to normal brains. RNA-Seq results suggested that inhibitors suppressed tumor-promoting genes while inducing tumor-suppressive genes. Furthermore, the studies conducted on subcutaneous and orthotopic GBM tumor xenograft models showed that administration of CDK9 inhibitors markedly suppressed tumor growth in vivo. Conclusions Our results suggest that CDK7 and CDK9 targeted therapies may be effective against TMZ-sensitive and resistant GBM.
    Type of Medium: Online Resource
    ISSN: 1522-8517 , 1523-5866
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2023
    detail.hit.zdb_id: 2094060-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Elsevier BV ; 1991
    In:  Cell Vol. 65, No. 6 ( 1991-6), p. 1053-1061
    In: Cell, Elsevier BV, Vol. 65, No. 6 ( 1991-6), p. 1053-1061
    Type of Medium: Online Resource
    ISSN: 0092-8674
    RVK:
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 1991
    detail.hit.zdb_id: 187009-9
    detail.hit.zdb_id: 2001951-8
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    MDPI AG ; 2015
    In:  Cancers Vol. 7, No. 3 ( 2015-07-31), p. 1447-1471
    In: Cancers, MDPI AG, Vol. 7, No. 3 ( 2015-07-31), p. 1447-1471
    Type of Medium: Online Resource
    ISSN: 2072-6694
    Language: English
    Publisher: MDPI AG
    Publication Date: 2015
    detail.hit.zdb_id: 2527080-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Stem Cells, Oxford University Press (OUP), Vol. 33, No. 6 ( 2015-06-01), p. 1705-1718
    Abstract: Non-small cell lung cancer (NSCLC) is highly correlated with smoking and has very low survival rates. Multiple studies have shown that stem-like cells contribute to the genesis and progression of NSCLC. Our results show that the transcriptional coactivator yes-associated protein 1 (YAP1), which is the oncogenic component of the Hippo signaling pathway, is elevated in the stem-like cells from NSCLC and contributes to their self-renewal and ability to form angiogenic tubules. Inhibition of YAP1 by a small molecule or depletion of YAP1 by siRNAs suppressed self-renewal and vascular mimicry of stem-like cells. These effects of YAP1 were mediated through the embryonic stem cell transcription factor, Sox2. YAP1 could transcriptionally induce Sox2 through a physical interaction with Oct4; Sox2 induction occurred independent of TEAD2 transcription factor, which is the predominant mediator of YAP1 functions. The binding of Oct4 to YAP1 could be detected in cell lines as well as tumor tissues; the interaction was elevated in NSCLC samples compared to normal tissue as seen by proximity ligation assays. YAP1 bound to Oct4 through the WW domain, and a peptide corresponding to this region could disrupt the interaction. Delivery of the WW domain peptide to stem-like cells disrupted the interaction and abrogated Sox2 expression, self-renewal, and vascular mimicry. Depleting YAP1 reduced the expression of multiple epithelial-mesenchymal transition genes and prevented the growth and metastasis of tumor xenografts in mice; overexpression of Sox2 in YAP1 null cells rescued these functions. These results demonstrate a novel regulation of stem-like functions by YAP1, through the modulation of Sox2 expression. Stem Cells  2015;33:1705–1718
    Type of Medium: Online Resource
    ISSN: 1066-5099 , 1549-4918
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2015
    detail.hit.zdb_id: 2030643-X
    detail.hit.zdb_id: 1143556-2
    detail.hit.zdb_id: 605570-9
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2015
    In:  Cancer Research Vol. 75, No. 15_Supplement ( 2015-08-01), p. 2085-2085
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 75, No. 15_Supplement ( 2015-08-01), p. 2085-2085
    Abstract: Nicotine, the addictive component of tobacco smoke, is known to promote proliferation, migration, and invasion of multiple cancer cells, including those of the lung and the pancreas. In addition, nicotine can promote the growth and metastasis of such cancers in mouse xenograft models. More recently, nicotine has also been implicated in promotion of cancer stem cell properties such as self-renewal. Our lab has shown that stimulation of lung cancer cells with nicotine results in activation of Src kinase in a β-arrestin-1 dependent manner, resulting in inactivation of the Rb tumor suppressor protein and subsequently the activation of E2F-mediated transcription of proliferative and survival genes. In addition to proliferative and survival genes, the E2F family of transcription factors has been shown to activate genes like matrix metalloproteinases that are involved in invasion and migration, indicating a role for E2F in the growth and metastasis of cancers downstream of nicotine. Our recent studies have shown that E2F1 can also induce genes which promote stemness, such as Stem Cell Factor (SCF/c-kit ligand), promoting nicotine-mediated enhancement of self-renewal of stem-like cells. In addition to these findings, here we demonstrate the ability of nicotine to induce the embryonic stem cell factor Sox2, which is indispensable for self-renewal and maintenance of stem cell properties, as well as the ability of E2F1 transcription factor to regulate Sox2 gene expression in non-small cell lung cancer cells. Western blot analysis revealed an induction of Sox2 protein at 18 and 24 hours post nicotine stimulation, which diminished by 48 hours. Similarly, quantitative real time PCR analysis showed an increase in Sox2 mRNA levels at 18 and24, hours post nicotine stimulation. Analysis of a 1500bp region of the human Sox2 gene promoter revealed multiple predicted E2F binding sites. Chromatin immunoprecipitation assays demonstrated E2F transcription factors to associate with the Sox2 promoter at multiple predicted binding sites. Transient transfection experiments further demonstrated the ability of E2F1 to induce the expression of a Sox2-luciferase reporter. These results suggest that nicotine may enhance lung cancer stem cell properties in part through the induction of Sox2, and this could potentially be mediated via E2F transcriptional activation. Further studies are underway to elucidate the impact of nicotine mediated induction of Sox2 on stemness, the underlying mechanism of activation, and the implications this has for non-small cell lung cancer. These studies can be expected to have a direct impact on our understanding of the molecular mechanism involved in the initiation, growth and metastasis of non-small cell lung cancer, especially in smokers. Citation Format: Courtney Schaal, Namrata Bora Singhal, Smitha Pillai, Jonathan Nguyen, Srikumar Chellappan. Nicotine-mediated regulation of Sox2 and its implications in the biology of non-small cell lung adenocarcinoma stem-like cells. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2085. doi:10.1158/1538-7445.AM2015-2085
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2015
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2010
    In:  Cancer Research Vol. 70, No. 8_Supplement ( 2010-04-15), p. 4309-4309
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 70, No. 8_Supplement ( 2010-04-15), p. 4309-4309
    Abstract: Lung cancer is the leading cause of death from cancer worldwide. NSCLC represents the most common subtype of lung cancer with the average five-year survival rate is only 16%. The majorities of these tumors are refractory to chemotherapeutics or acquire resistance to the therapy. In addition, most of the patients develop distant metastases even tough their primary tumors are surgically removed. Cancer stem cell hypothesis has emerged as a possible explanation for tumor growth, recurrence after treatment and metastasis in a variety of cancer. This hypothesis suggests that tumors are maintained by the subset of cancer stem cells (CSCs) that has the ability to self-renew and generate the diverse cells that comprise the tumor. While evidence supporting the existence of CSCs has been demonstrated in many solid cancers, it is largely underdeveloped in lung cancer. Here we have isolated cancer stem like cells from NSCLC cell lines either through isolating the side population (SP) cells based on their property to exclude Hoechst 33342 dye or enriched them by cultivating cancer cells in defined serum free medium containing N2-supplement, EGF and bFGF. Cells obtained from both these methods demonstrated higher clonogenic as well as sphere forming ability which is the typical characteristics associated with CSCs. We further characterized these cells for their ability to express progenitor/stem cell marker genes like Oct4, Sox2 and Nanog. Total RNA from SP cells showed higher expression of these genes as compared to main population. Similarly, the expression of Oct4, Sox2 and Nanog was found elevated after culturing H1650, H358, H322 and H292 cells in defined serum free medium for 10 days. Interestingly, CSCs enriched in this condition also showed the loss of E-cadherin expression and consequent gain of mesenchymal proteins like fibronectin and vimentin. Additionally, ABCG2, which is closely associated with the drug resistance and responsible for side population phenotype, was also upregulated in cancer stem like cells enriched from culturing in serum free defined media. In conclusion, results revealed that lung cancer stem like cells could be isolated and expanded from the established lung cancer cell lines by two different methodologies described here. These cells possess the characteristics of both stem cells and malignant tumors. Therefore, further studies towards targeting these cells may result in effective therapy against lung cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4309.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2010
    In:  Cancer Research Vol. 70, No. 8_Supplement ( 2010-04-15), p. 2951-2951
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 70, No. 8_Supplement ( 2010-04-15), p. 2951-2951
    Abstract: Cigarette smoking is strongly correlated with the onset of non-small cell lung cancer. Nicotine, an active component of tobacco smoke has been found to induce proliferation, invasion and epithelial-mesenchymal transition in NSCLC cell lines. While nicotine by itself is not carcinogenic, it can induce cell proliferation utilizing a scaffolding protein, β-arrestin-1 which translocates to nucleus and associates with E2F1 transcription factor. In addition, nicotine induces changes in gene expression consistent with epithelial-mesenchymal transition characterized by increase in the levels of mesenchymal proteins like vimentin and fibronectin. In this study we demonstrate that mesenchymal markers such as vimentin and fibronectin are E2F1 regulated and β-arrestin-1 is involved in regulating their expression in response to nicotine stimulation. Analysis of vimentin and fibronectin promoters revealed the presence of potential E2F binding sites. Transient transfection experiments in A549 cells using vimentin and fibronectin promoter constructs showed that these promoters were induced significantly by E2F1 and repressed by Rb. Depletion of E2F1 using siRNAs resulted in down regulation of vimentin and fibronectin as seen by Real-Time PCR. Chromatin immunoprecipitation assays on quiescent as well as nicotine stimulated A549 cells showed a robust recruitment of E2F1 and β-arrestin-1 to vimentin and fibronectin promoters. In addition, depletion of β-arrestin-1 resulted in down regulation of vimentin and fibronectin expression as revealed by western blot and Real-Time PCR. Nicotine stimulation resulted in the induction of vimentin and fibronectin promoters when A549 cells were transfected with reporter constructs while β-arrestin-1 depleted cells did not show promoter induction with nicotine stimulation. Boyden chamber assays conducted on β-arrestin-1 knocked down cells showed that ablation of β-arrestin-1 resulted in the inhibition of nicotine induced migratory and invasive potential of cells. Taken together, these data suggest that β-arrestin-1 contributes to nicotine induced epithelial-mesenchymal transition by regulating E2F1 mediated vimentin and fibronectin expression. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2951.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2011
    In:  Cancer Research Vol. 71, No. 8_Supplement ( 2011-04-15), p. 5048-5048
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 5048-5048
    Abstract: Introduction: Predicting and overcoming drug resistance is a major difficulty facing the efficacy of drugs in clinical trials. Histone deacetylase inhibitors (HDACis) are known to induce cell death and have been used in clinic trials as anticancer drugs, however, the cytotoxic effects of HDACis remains to be limited with no clear mechanism of resistance has been elucidated to explain this limited efficacy. In this study we showed that downregulation of the G2 checkpoint kinase 1 (Chk1) plays an essential role in inducing cell death by HDACis. We identified E2F as a main regulator of Chk1 expression in cancer cells, suggesting that inhibition of Chk1 through E2F may enhance the cytotoxic effects of HDACis in clinical studies. Methods: A549, H1299, PC9, HCT116, HT1080, MNNG, H2172, Saos-2, MG63, U2OS, p21-/- and p21+/+ MEF cell lines were grown in appropriate medium and treated with the HDAC inhibitors, SaHa, LBH589 or MS275. Western blot and qRT-PCR experiments were performed to assess the effect of HDACis on Chk1/G2-M checkpoint pathways and on E2F-mediated gene expression profiles. Additionally, knock out and gain of function experiments were done to better understand the interaction between Chk1, E2F and p21Waf1 in HDACi mediated cell death. The results of the in vitro cell lines studies were corroborated in the ex vivo experiments with patient tumor tissue. Results: We showed that HDACi treatment leads to inhibition of Chk1 expression and consequently to increased activity of CDC25 and CDC2 (CDK1) enzymes causing premature mitotic entry and cell death. In the knock-down experiments we found that inhibition of E2F1 or E2F3 leads to reduction of Chk1 expression and potentiation of cell death by HDACis. Similar results were observed using patient-derived tumor samples treated with SaHa and an E2F inhibitor (HLM006474). Additionally, over-expression of E2F1 or E2F3 dramatically decreased HDACi-mediated cell death. In time course experiments, Chk1 as well as other E2F-responsive genes were down regulated after HDACi treatment accompanied by an expected p21Waf1 induction. In p21Waf1 +/+ and -/- MEFs we showed that lack of p21Waf1 results in increased apoptosis, suggesting that early induction of p21Waf1 by HDACis negatively regulates HDACi-induced cell death, which likely contributes to HDACi resistance in tumor cells by preventing cells to undergo mitotic cell death. Conclusions: Our results demonstrate that E2F-mediated downregulation of Chk1 plays a key role in HDACi-induced cell. We provide evidence that lack of Chk1 downregulation and activation of CDC2 is associated with resistance to HDACis indicating that Chk1 may represent a clinically relevant biomarker to assess the efficacy of HDACis in patient tumor samples. Taken together our data lends insight into the molecular mechanism of sensitivity and resistance to HDACi-induced cell death and will hopefully provide a stronger foundation for future clinical translation with HDACis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 5048. doi:10.1158/1538-7445.AM2011-5048
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2006
    In:  Cancer Research Vol. 66, No. 14 ( 2006-07-15), p. 7361-7369
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 66, No. 14 ( 2006-07-15), p. 7361-7369
    Abstract: Previously, we showed that N-methyl-N-nitrosourea–transformed MCF12F breast epithelial cells exhibited differential expression of several genes, including up-regulation of prohibitin and elevated sensitivity to a relatively noncalcemic vitamin D analogue, 1α-hydroxyvitamin D5 [1α(OH)D5]. In this report, we evaluated the functional significance of prohibitin in relation to the cellular response to vitamin D. The in silico screening for putative transcription factor binding sites identified two vitamin D receptor (VDR)/retinoid X receptor binding sites in the 1-kb promoter region of prohibitin. Prohibitin up-regulation by 1α(OH)D5 treatment at both transcriptional and translational levels was confirmed by real-time reverse transcription-PCR and Western blot analysis in breast cancer cells, identifying prohibitin as a vitamin D target gene. Confocal microscopic analysis showed that prohibitin was localized in the nuclei of MCF-7 cells and a portion of prohibitin was colocalized with VDR, but direct physical interaction between VDR and prohibitin in cell lysates was not detectable. In MCF-7 cells expressing tetracycline-inducible prohibitin (Tet-On model), the overexpression of prohibitin inhibited cell proliferation and enhanced vitamin D–induced antiproliferative activity. Knockdown of prohibitin was accompanied by increased number of cells incorporating bromodeoxyuridine in the whole population and increased cell distribution in the S phase of cell cycle. In addition, prohibitin level had no significant effect on the vitamin D–induced transactivation of CYP24, a VDR target gene. This is the first report to suggest that prohibitin serves as a novel vitamin D target gene, which is involved in the antiproliferative action of vitamin D without affecting CYP24 transactivation in breast cancer cells. (Cancer Res 2006; 66(14): 7361-9)
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2006
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2010
    In:  Cancer Research Vol. 70, No. 12 ( 2010-06-15), p. 4931-4940
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 70, No. 12 ( 2010-06-15), p. 4931-4940
    Abstract: E2F transcription factors regulate a variety of cellular processes, but their role in angiogenesis is not clear. We find that many genes involved in angiogenesis such as FLT-1, KDR, and angiopoietin 2 have potential E2F1 binding sites in their promoter. Chromatin immunoprecipitation (ChIP) assays showed that E2F1 can associate with these promoters and the recruitment of E2F1 was enhanced upon vascular endothelial growth factor (VEGF) stimulation with concomitant dissociation of Rb, leading to the transcriptional activation of these promoters. Transient transfection experiments showed that these promoters were induced by E2F1 and repressed by Rb, whereas depletion of E2F1 decreased their expression. The increased binding of E2F1 to these promoters upon VEGF stimulation correlated with the acetylation of histones and E2F1; this required VEGF receptor function, as seen in ChIP-re-ChIP experiments. This suggests the existence of a positive feedback loop regulating E2F1 acetylation and VEGF receptor expression. Acetylation associated with VEGF signaling seems to be predominantly mediated by P300/CBP-associated factor, and the depletion of histone acetyl transferases disrupted the formation of angiogenic tubules. These results suggest a novel role for E2F1 and acetylation in the angiogenic process. Cancer Res; 70(12); 4931–40. ©2010 AACR.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...